These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 22882693

  • 1. Multidrug-resistant Klebsiella pneumoniae acquisition in lung transplant recipients.
    Raviv Y, Shitrit D, Amital A, Fox B, Bakal I, Tauber R, Bishara J, Kramer MR.
    Clin Transplant; 2012; 26(4):E388-94. PubMed ID: 22882693
    [Abstract] [Full Text] [Related]

  • 2. Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients.
    Kalpoe JS, Sonnenberg E, Factor SH, del Rio Martin J, Schiano T, Patel G, Huprikar S.
    Liver Transpl; 2012 Apr; 18(4):468-74. PubMed ID: 22467548
    [Abstract] [Full Text] [Related]

  • 3. Carbapenem-resistant Klebsiella pneumoniae urinary tract infection following solid organ transplantation.
    Brizendine KD, Richter SS, Cober ED, van Duin D.
    Antimicrob Agents Chemother; 2015 Jan; 59(1):553-7. PubMed ID: 25385105
    [Abstract] [Full Text] [Related]

  • 4. Carbapenem-resistant Klebsiella pneumoniae infections in kidney transplant recipients: a case-control study.
    Simkins J, Muggia V, Cohen HW, Minamoto GY.
    Transpl Infect Dis; 2014 Oct; 16(5):775-82. PubMed ID: 25092500
    [Abstract] [Full Text] [Related]

  • 5. Epidemiology of an outbreak of antibiotic-resistant Klebsiella pneumoniae at a tertiary care medical center.
    Filozov A, Visintainer P, Carbonaro C, Aguero-Rosenfeld M, Wormser GP, Montecalvo MA.
    Am J Infect Control; 2009 Nov; 37(9):723-8. PubMed ID: 19501935
    [Abstract] [Full Text] [Related]

  • 6. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae A case-control study.
    Mosqueda-Gómez JL, Montaño-Loza A, Rolón AL, Cervantes C, Bobadilla-del-Valle JM, Silva-Sánchez J, Garza-Ramos U, Villasís-Keever A, Galindo-Fraga A, Palacios GM, Ponce-de-León A, Sifuentes-Osornio J.
    Int J Infect Dis; 2008 Nov; 12(6):653-9. PubMed ID: 18511321
    [Abstract] [Full Text] [Related]

  • 7. Characterization of an outbreak due to extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a pediatric intensive care unit transplant population.
    Rebuck JA, Olsen KM, Fey PD, Langnas AN, Rupp ME.
    Clin Infect Dis; 2000 Dec; 31(6):1368-72. PubMed ID: 11096004
    [Abstract] [Full Text] [Related]

  • 8. Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates.
    Lee CH, Su LH, Tang YF, Liu JW.
    J Antimicrob Chemother; 2006 Nov; 58(5):1074-7. PubMed ID: 16971415
    [Abstract] [Full Text] [Related]

  • 9. Impact of extended spectrum beta-lactamase producing Klebsiella pneumoniae infections in severely burned patients.
    Bennett JW, Robertson JL, Hospenthal DR, Wolf SE, Chung KK, Mende K, Murray CK.
    J Am Coll Surg; 2010 Sep; 211(3):391-9. PubMed ID: 20800197
    [Abstract] [Full Text] [Related]

  • 10. An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum beta-lactamase.
    Peña C, Pujol M, Ardanuy C, Ricart A, Pallarés R, Liñares J, Ariza J, Gudiol F.
    J Hosp Infect; 2001 Jan; 47(1):53-9. PubMed ID: 11161899
    [Abstract] [Full Text] [Related]

  • 11. Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae.
    Hussein K, Raz-Pasteur A, Finkelstein R, Neuberger A, Shachor-Meyouhas Y, Oren I, Kassis I.
    J Hosp Infect; 2013 Apr; 83(4):307-13. PubMed ID: 23313086
    [Abstract] [Full Text] [Related]

  • 12. Risk factors and mortality for patients with Bloodstream infections of Klebsiella pneumoniae during 2014-2018: Clinical impact of carbapenem resistance in a large tertiary hospital of China.
    Chang H, Wei J, Zhou W, Yan X, Cao X, Zuo L, Chen S, Yao K, Huang R, Chen Y, Wu C.
    J Infect Public Health; 2020 May; 13(5):784-790. PubMed ID: 31843651
    [Abstract] [Full Text] [Related]

  • 13. Impact of carbapenem resistance on epidemiology and outcomes of nonbacteremic Klebsiella pneumoniae infections.
    Ny P, Nieberg P, Wong-Beringer A.
    Am J Infect Control; 2015 Oct 01; 43(10):1076-80. PubMed ID: 26190386
    [Abstract] [Full Text] [Related]

  • 14. Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections.
    Viale P, Giannella M, Lewis R, Trecarichi EM, Petrosillo N, Tumbarello M.
    Expert Rev Anti Infect Ther; 2013 Oct 01; 11(10):1053-63. PubMed ID: 24073806
    [Abstract] [Full Text] [Related]

  • 15. Risk Factors for Carbapenem-resistant Klebsiella pneumoniae Infection and Mortality of Klebsiella pneumoniae Infection.
    Wang Z, Qin RR, Huang L, Sun LY.
    Chin Med J (Engl); 2018 Jan 05; 131(1):56-62. PubMed ID: 29271381
    [Abstract] [Full Text] [Related]

  • 16. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
    Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW.
    Antimicrob Agents Chemother; 2004 Dec 05; 48(12):4574-81. PubMed ID: 15561828
    [Abstract] [Full Text] [Related]

  • 17. The effect of control group selection in the analysis of risk factors for extended spectrum beta-lactamase-producing Klebsiella pneumoniae infections. A prospective controlled study.
    Behar PR, Teixeira PJ, Fachel JM, Kalil AC.
    J Hosp Infect; 2008 Feb 05; 68(2):123-9. PubMed ID: 18192077
    [Abstract] [Full Text] [Related]

  • 18. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in paediatric wards: a nested case-control study.
    Demir S, Soysal A, Bakir M, Kaufmann ME, Yagci A.
    J Paediatr Child Health; 2008 Oct 05; 44(10):548-53. PubMed ID: 18557808
    [Abstract] [Full Text] [Related]

  • 19. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K, Wong SS, Lin LC, Tsai CR, Chen LC, Huang CH.
    J Microbiol Immunol Infect; 2012 Jun 05; 45(3):193-9. PubMed ID: 22580086
    [Abstract] [Full Text] [Related]

  • 20. Risk factors and outcome of infections with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in kidney transplant recipients.
    Freire MP, Abdala E, Moura ML, de Paula FJ, Spadão F, Caiaffa-Filho HH, David-Neto E, Nahas WC, Pierrotti LC.
    Infection; 2015 Jun 05; 43(3):315-23. PubMed ID: 25690848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.